Synchronized Transcranial Magnetic Stimulation for PTSD
Part of paid clinical trials in Providence, Rhode Island.
- Sponsor
- Providence VA Medical Center
- Study ID
- NCT02981381
- Status
- Completed
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 70 Years
- Healthy Volunteers
- Not accepted
Interventions
- NEST-1 — DEVICEThe NeoSync EEG Synchronized TMS (NEST) is an electromechanical medical device that produces and delivers a sinusoidal magnetic field to areas of the brain in the treatment of PTSD. The device includes an EEG recording module that is used to record individualized alpha frequency (IAF) on randomized personal passport modules (PPM) pre-assigned to be NEST-1 compatible.
- SHAM — DEVICEThe SHAM NeoSync EEG Synchronized TMS (NEST) is a device, identical to the active NEST-1 device, that is configured to simulate the delivery of active treatment without actively delivering sTMS therapy. The device includes an EEG recording module that is used to record individualized alpha frequency (IAF) on randomized personal passport modules (PPM) pre-assigned to be SHAM compatible.
- NEST-2 — DEVICEThe open-label NeoSync EEG Synchronized TMS (NEST) that produces and delivers a sinusoidal magnetic field to areas of the brain in the treatment of PTSD. The device is distinct in both color and sound both SHAM and NEST-1 devices. PPMs corresponding with both SHAM and NEST-1 devices are compatible with the NEST-2 device.
Study Details
The investigators propose a small, two-site, sham-controlled pilot study of synchronized Transcranial Magnetic Stimulation (sTMS) in patients with comorbid post-traumatic stress disorder (PTSD) and depression. It is hypothesized that sTMS will be effective for PTSD and mood symptoms.
Key Dates
- Start date
- Oct 13, 2016
- Status verified
- May 2025
- Primary completion
- Oct 26, 2018
- Completion
- Oct 26, 2018
Study Design
- Enrollment
- 23 participants (actual)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Active sTMS (NEST-1)Subjects randomized to this group will receive 20 active synchronized Transcranial Magnetic Stimulation (sTMS) treatments (30 minutes each) over a period of 40 calendar days. Treatment windows will be 10 calendar days to complete 5 active sTMS sessions. Serial assessments will be completed every 5 sessions. Post-treatment (PT1) endpoint assessments will take place on the last day of active sTMS. Participants that elect to participate in the open-label continuation phase, will receive an additional 20 sTMS treatments (using the NEST-2 device), following the same administration structure as the sham-control series. Participants will return to complete post-treatment follow-up assessments (PT2) 1 month after their last treatment session (either PT1 or OL PT1).
- Sham Comparator: Sham sTMS (SHAM)Subjects randomized to this group will receive 20 sham synchronized Transcranial Magnetic Stimulation (sTMS) treatments (30 minutes each) over a period of 40 calendar days. Treatment windows will be 10 calendar days to complete 5 sham sessions. Serial assessments will be completed every 5 sessions. Post-treatment (PT1) endpoint assessments will take place immediately after the final sham session. Participants that elect to participate in the open-label continuation phase, will receive 20 sTMS treatments (using the NEST-2 device), following the same administration structure as the sham-control series. Participants will return to complete post-treatment follow-up assessments (PT2) 1 month after their last treatment session (either PT1 or OL PT1).
Primary Outcome Measure
PCL-5 Total Score Change [ Time Frame: 1 month after final treatment (approximately 70 days total) ]
Locations (2)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Providence VAMC | Providence | Rhode Island | 02906 | - |
| White River Junction VAMC | White River Junction | Vermont | 05009 | - |
Find similar trials in Providence, RI
By condition
By specialty
Related Studies
- Brain Connectivity in DepressionRecruiting · Brigham and Women's Hospital · Boston, Massachusetts
- Testing a Lifestyle Physical Activity Intervention for Women With Depression in Alcohol TreatmentRecruiting · Butler Hospital · Providence, Rhode Island
- Developing and Testing an Online Pathway From Screening to Treatment for Depression in Oncology: iPath*D (Aim 2)Recruiting · Dartmouth-Hitchcock Medical Center · Saint Johnsbury, Vermont
- Mood and Thought Process StudyRecruiting · Butler Hospital · Providence, Rhode Island